Prevalence of Regular Gynecological Follow-up Among Women of Childbearing Age

NCT07424937 | Completed

• 1 other identifier: 2025_RIPH_17_SF_A Fillion
• Study Type: observational
• Target: 395
• Locations: 1 country
• Sites: 1

Brief Summary

The French National Authority for Health (Haute Autorité de Santé, HAS) recommends regular gynecological follow-up, specifying that it is considered regular when it is annual. The objectives of this gynecological follow-up are multiple: to support women in the choice and management of contraception as well as in their sexuality; to screen for cervical cancer and breast cancer; to diagnose and to take care of sexually transmitted infections (STIs); and to diagnose and treat gynecological conditions such as adenomyosis, endometriosis, polycystic ovary syndrome, etc. Regarding cervical cancer screening, the HAS recommends performing a Pap smear (cervical cytology) starting at the age of 25 and up to the age of 65. Several studies, such as those by Henry et al. in 2020 and Owokuhaisa et al. in 2024, have identified major barriers to access to gynecological care for women. These barriers include very long waiting times, lack of privacy, lack of understanding or access to appropriate information, discomfort or fear during consultations, shortage of physicians, past negative experiences, etc. These factors may contribute to women postponing or even forgoing their gynecological consultations. A study by Landy et al. in 2021 also showed that women diagnosed with advanced-stage cervical cancer had not undergone regular screening or gynecological follow-up.

Conditions

Gynecological Follow-up

Keywords

gynecological follow-up; regular; childbearing age; woman

Outcome Measures

Primary Outcomes (1)

• The prevalence of regular gynecological follow-up

  Regular gynecological follow-up (according to HAS recommendations: once per year) and, if irregular, the frequency of follow-up: once every two to three years, occasionally, more than three years ago, or never consulted

  Day 0

Interventions

data collection OTHER

data collection

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult women, non-menopausal, with or without desire for pregnancy, not pregnant, and agreeing to participate in the study

You may qualify if:

• Women aged 18 years and over
• Are not menopausal
• Have or do not have a desire for pregnancy
• Have children or do not have children
• Have a sexual partner or not
• Reside in metropolitan France or in the French overseas department.
• Agreeing to participate in the study

You may not qualify if:

• Being pregnant
• Being legally protected (guardianship, curatorship, judicial protection)

Sponsors & Collaborators

• Université de Reims Champagne-Ardenne: lead

Study Sites (1)

Ufr Medecine Urca

Reims, 51100, France

Location

MeSH Terms

Interventions

Data Collection

Intervention Hierarchy (Ancestors)

Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 13, 2026
• First Posted: February 20, 2026
• Study Start: December 1, 2025
• Primary Completion: January 30, 2026
• Study Completion: February 1, 2026
• Last Updated: February 20, 2026

Record last verified: 2026-02

Locations

FR (1)